ARAY
Accuray
–
Index: NASDAQ; Sector: Healthcare; Industry: Medical Equipment & Supplies;
Marketcap: 220.70M; Volume: 75.87K; AvgVol 3m: 603.43K; Beta: –;
Cost estimate:
P/E: 59.33; EPS: 0.04; EPS growth quarter/prev quarter: 89.40%;
EPS growth this year: 122.50%; EPS growth past 5 years: 15.80%;
EPS ttm: 0.04;
P/S: 0.63; P/B: 3.83; P/Cashflow: 2.25; P/FCF: ;
Sales: 382.94M; Sales growth quarter/prev quarter: -19.10%; Sales growth past 5 years: 0.20%;
Profitability:
Gross Margin: 39.10%; Profit Margin: 1.00%; Operating Margin: 3.30%;
ROA – return on assets: 0.80%; ROE – return on equity: 6.90%; LT Debt/Equity: 2.98; Total Debt/Equity: 2.98;
Dividend: –; Dividend Yield (%): –;
Insider Ownership: 0.30%; Insider Transactions:-8.13%;
Institutional Ownership: 74.80%; Institutional Transactions: 1.47%;
Data update: 07.10.2020.